Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy Adjuvant”

1,359 trials

Showing 20 of 1,359 results

Not applicableUnknownNCT01905969
What this trial is testing

Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant Chemotherapy

Who this might be right for
Gastric Cancer
Iwate Medical University 500
Testing effectiveness (Phase 2)Study completedNCT00777491
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery

Who this might be right for
Bladder Cancer
Radiation Therapy Oncology Group 70
Testing effectiveness (Phase 2)Study completedNCT00089024
What this trial is testing

Combination Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Nebraska 29
Testing effectiveness (Phase 2)UnknownNCT06341842
What this trial is testing

Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity

Who this might be right for
Breast Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 316
Not applicableEnded earlyNCT04372992
What this trial is testing

The Stoma Closure Before or After Adjuvant Therapy Trial

Who this might be right for
IleostomyRectal Cancer
Ospedale Umberto I di Torino 14
Post-approval studies (Phase 4)Not Yet RecruitingNCT07132528
What this trial is testing

Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer

Who this might be right for
Gastric / Gastroesophageal Junction Adenocarcinoma
Liaoning Cancer Hospital & Institute 1,000
Post-approval studies (Phase 4)Study completedNCT03413436
What this trial is testing

Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma

Who this might be right for
Esophageal Cancer
Henan Cancer Hospital 733
Testing effectiveness (Phase 2)Ended earlyNCT02795572
What this trial is testing

Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Who this might be right for
Peripheral Neuropathy in Breast Cancer Patient
AHS Cancer Control Alberta 13
Testing effectiveness (Phase 2)Study completedNCT03984357
What this trial is testing

Nivolumab Combined With Chemoradiotherapy Sparing Concurrent Cisplatin in Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 152
Early research (Phase 1)Ended earlyNCT02492477
What this trial is testing

TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients

Who this might be right for
Adjuvant ChemotherapySolid TumoursPort-A-Cath
Krankenhaus Barmherzige Schwestern Linz 4
Not applicableEnded earlyNCT00126867
What this trial is testing

Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment

Who this might be right for
Colon Cancer
AHS Cancer Control Alberta 29
Large-scale testing (Phase 3)Looking for participantsNCT06609551
What this trial is testing

CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study

Who this might be right for
Colon CancerColon Cancer (Stage II &Amp;Amp;Amp; III)
Zhejiang Cancer Hospital 312
Large-scale testing (Phase 3)UnknownNCT01795027
What this trial is testing

Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer

Who this might be right for
Gastric Cancer
Sun Yat-sen University 724
Not applicableUnknownNCT01680575
What this trial is testing

Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian Cancer
Asan Medical Center 750
Large-scale testing (Phase 3)UnknownNCT02502370
What this trial is testing

Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma

Who this might be right for
Small Bowel AdenocarcinomaAdjuvant Chemotherapy for SBA
Centre Hospitalier Universitaire Dijon 100
Large-scale testing (Phase 3)Looking for participantsNCT06293625
What this trial is testing

Personalising and Refining Neo-adjuvant Chemotherapy in Locally Advanced but Resecable Colon Cancer in the Elderly of 70 Years Old or More

Who this might be right for
Colon Cancer
Centre Hospitalier Universitaire Dijon 150
Large-scale testing (Phase 3)Study completedNCT01640782
What this trial is testing

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach

Who this might be right for
Adenocarcinoma of the StomachAdenocarcinoma of the Gastroesophageal Junction
Mario Negri Institute for Pharmacological Research 1,100
Not applicableStudy completedNCT03585218
What this trial is testing

Women With Breast Cancer Undergoing Chemotherapy: Implications in Quality of Life

Who this might be right for
Breast Cancer Female
University of Minho 112
Large-scale testing (Phase 3)Looking for participantsNCT07643623
What this trial is testing

Neoadjuvant and Adjuvant Therapy Studies of Sintilimab Combined With Chemotherapy With or Without Ipilimumab N01 in Resectable Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Resectable Gastric/Gastroesophageal Junction Adenocarcinoma
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. 720
Not applicableStudy completedNCT06363084
What this trial is testing

A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Ruijin Hospital 64
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation